For the most part, developing new medical technologies is a huge benefit to people. Take for instance the smart pill that the U.S. Food and Drug Administration (FDA) just approved, which is meant to monitor if patients are sticking to their medication schedule. While incredibly useful, it could also allow entities like the U.S. government to spy on its citizens even more intrusively than it does now.
No one likes to be spied on and yet this is exactly what concerned privacy groups are saying could happen with the digital pill that the FDA just approved for use. Called the Abilify MyCite, the pill comes with sensors that basically indicate if patients just took their medication, Futurism reports.
Abilify is a drug used to treat neurological conditions such as schizophrenia and bipolar disorders. The sensor is embedded in the pill, where it will send out a signal once it comes in contact with the stomach. This signal will be picked up by a patch on the patient’s left rib cage, which will then notify the monitoring personnel via the accompanying app.
The information that the sensors can send out can include the dosage, the exact time when the pill was taken, and even what the patient was doing at the time. Because of how intrusive the data mining process appears, groups concerned about potential abuses are speaking out. They are especially worried about potential punitive actions against patients who are committing what’s called nonadherence.
Basically, nonadherence or noncompliance refers to patients not taking their medication as they are supposed to. This leads to patients getting sicker, which then leads to higher medical costs due to the increased medical attention that they need. Apparently, this particular trend costs $100 billion a year, the New York Times reports.
There’s also the concern of medical professionals that a smart pill could lead to a feeling of coercion on the part of the patients. Subjects could feel pressured to take their medication because their doctors are monitoring them.


US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Tabletop particle accelerator could transform medicine and materials science
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment
Google Halts UK YouTube TV Measurement Service After Legal Action
Microsoft AI Spending Surge Sparks Investor Jitters Despite Solid Azure Growth
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Apple Forecasts Strong Revenue Growth as iPhone Demand Surges in China and India
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay 



